STOCK TITAN

Telescope Innovations Receives CICE Funding to Pilot Lithium Refinement Technology

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) has been awarded $400,273 in early-stage funding from the B.C. Centre for Innovation and Clean Energy (CICE) to pilot its proprietary Recrystallization Refinement Technology (ReCRFT™). This technology is a carbon-negative and low-cost method to produce battery-grade lithium carbonate from saltwater brines.

ReCRFT is inspired by pharmaceutical manufacturing approaches and offers advantages such as continuous operation, high process yield, high impurity tolerance, and reduced reagent utilization. It is estimated to reduce lithium refinery plant CapEx by 15-25% and OpEx by 25% compared to incumbent technologies.

The funding will support Telescope's lab-scale pilot, providing key engineering studies and continuous operation demonstrations for potential licensing customers. This project builds on Telescope's previous research efforts with Standard Lithium, Natural Resources Canada, and Canada's Mining Innovation Commercialization Accelerator.

Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ha ricevuto 400.273 dollari di finanziamenti iniziali dal B.C. Centre for Innovation and Clean Energy (CICE) per pilotare la sua tecnologia proprietaria Recrystallization Refinement Technology (ReCRFT™). Questa tecnologia è un metodo a basse emissioni di carbonio e a basso costo per produrre carbonato di litio di grado batterie da salamoia di acqua salata.

ReCRFT si ispira agli approcci di produzione farmaceutica e offre vantaggi come operazione continua, elevata resa del processo, alta tolleranza alle impurità e ridotto utilizzo di reagenti. Si stima che riduca il CapEx degli impianti di raffinazione del litio del 15-25% e il OpEx del 25% rispetto alle tecnologie esistenti.

I finanziamenti sosterranno il pilotaggio su scala di laboratorio di Telescope, fornendo studi ingegneristici chiave e dimostrazioni di operazione continua per potenziali clienti di licenza. Questo progetto si basa sugli sforzi di ricerca precedenti di Telescope con Standard Lithium, Natural Resources Canada e l'Acceleratore per l'Innovazione Mineraria del Canada.

Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ha recibido 400.273 dólares en financiación en etapas tempranas del B.C. Centre for Innovation and Clean Energy (CICE) para pilotar su tecnología patentada Recrystallization Refinement Technology (ReCRFT™). Esta tecnología es un método de carbono negativo y bajo costo para producir carbonato de litio de grado de batería a partir de salmueras de agua salada.

ReCRFT se inspira en los enfoques de fabricación farmacéutica y ofrece ventajas como operación continua, alta eficacia del proceso, alta tolerancia a impurezas y reducción en el uso de reactivos. Se estima que reduce el CapEx de las plantas de refinación de litio entre el 15-25% y el OpEx en un 25% en comparación con las tecnologías existentes.

La financiación apoyará el piloto a escala de laboratorio de Telescope, proporcionando estudios de ingeniería clave y demostraciones de operación continua para posibles clientes de licencias. Este proyecto se basa en los esfuerzos previos de investigación de Telescope con Standard Lithium, Natural Resources Canada y el Acelerador de Comercialización de Innovación en Minería de Canadá.

텔레스코프 이노베이션스 코퍼레이션 (CSE: TELI) (OTCQB: TELIF)은 B.C. 혁신 및 청정 에너지 센터 (CICE)로부터 자금 지원을 받아 400,273 달러를 확보하였습니다. 이는 자사의 독자적인 재결정 정제 기술 (ReCRFT™)을 시험하기 위한 것입니다. 이 기술은 염수에서 배터리급 탄산 리튬을 생산하기 위한 탄소 배출이 없는 저비용 방법입니다.

ReCRFT는 제약 제조 기법에서 영감을 얻었으며 지속적인 운영, 높은 공정 수율, 높은 불순물 허용도, 감소된 시약 사용 등의 장점을 제공합니다. 기존 기술에 비해 리튬 정제 공장에 대한 자본 비용(CapEx)을 15-25%, 운영 비용(OpEx)을 25% 줄이는 것으로 추정됩니다.

이번 자금 지원은 텔레스코프의 실험실 규모 시범 사업을 지원하며, 잠재 라이선스 고객을 위한 핵심 공학 연구 및 지속적인 운영 시연을 제공합니다. 이 프로젝트는 Standard Lithium, Natural Resources Canada 및 캐나다의 광업 혁신 상용화 가속기와의 이전 연구 노력에 기반합니다.

Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) a reçu 400.273 $ en financement de phase précoce du B.C. Centre for Innovation and Clean Energy (CICE) pour piloter sa technologie propriétaire Recrystallization Refinement Technology (ReCRFT™). Cette technologie est une méthode négative en carbone et à faible coût pour produire du carbonate de lithium de qualité batterie à partir de saumures salines.

ReCRFT s'inspire des approches de fabrication pharmaceutique et offre des avantages tels que fonctionnement continu, rendement élevé du processus, haute tolérance aux impuretés et réduction de l'utilisation des réactifs. On estime qu'elle réduit les CapEx des usines de raffinage de lithium de 15 à 25 % et le OpEx de 25 % par rapport aux technologies existantes.

Le financement soutiendra le projet pilote à l'échelle du laboratoire de Telescope, fournissant des études d'ingénierie clés et des démonstrations de fonctionnement continu pour de potentiels clients sous licence. Ce projet s'appuie sur les efforts de recherche précédents de Telescope avec Standard Lithium, Natural Resources Canada et l'Accelerator for Mining Innovation Commercialization du Canada.

Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) hat 400.273 Dollar an Frühphasenfinanzierung vom B.C. Centre for Innovation and Clean Energy (CICE) erhalten, um seine proprietäre Recrystallization Refinement Technology (ReCRFT™) zu erproben. Diese Technologie ist ein kohlenstoffnegativer und kostengünstiger Ansatz, um battery-grade Lithiumcarbonat aus Salzwasser-Einschlüssen zu produzieren.

ReCRFT ist von pharmazeutischen Herstellungsverfahren inspiriert und bietet Vorteile wie kontinuierliche Betriebsführung, hohe Prozessausbeute, hohe Unreinheitstoleranz und reduzierten Reagenzienverbrauch. Es wird geschätzt, dass es die Investitionskosten (CapEx) von Lithiumraffinerien um 15-25% und die Betriebskosten (OpEx) um 25% im Vergleich zu etablierten Technologien senkt.

Die Finanzierung wird das Labor-Pilotprojekt von Telescope unterstützen und wichtige Ingenieurstudien sowie Demonstrationen der kontinuierlichen Betriebsführung für potenzielle Lizenzkunden bereitstellen. Dieses Projekt baut auf den bisherigen Forschungsanstrengungen von Telescope mit Standard Lithium, Natural Resources Canada und dem Canadian Mining Innovation Commercialization Accelerator auf.

Positive
  • Received $400,273 in non-dilutive funding from CICE
  • ReCRFT technology estimated to reduce lithium refinery plant CapEx by 15-25% and OpEx by 25%
  • Lab-scale pilot to provide key engineering studies for potential licensing customers
  • Technology offers continuous operation, high process yield, and high impurity tolerance
Negative
  • None.

Vancouver, British Columbia--(Newsfile Corp. - July 22, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, has been awarded $400,273 in early-stage funding from the B.C. Centre for Innovation and Clean Energy ("CICE"). This non-dilutive investment will support Telescope's piloting of its proprietary Recrystallization Refinement Technology ("ReCRFT™"): a carbon-negative and low-cost method to produce battery-grade lithium carbonate from saltwater brines.

ReCRFT is inspired by established manufacturing approaches from the pharmaceutical industry that reliably produce large quantities of active pharmaceutical ingredients in high purity. ReCRFT enables low-cost production in 4 ways: i) continuous operation, ii) high process yield, iii) high impurity tolerance, and iv) reduced reagent utilization. Current estimates suggest that ReCRFT could reduce lithium refinery plant CapEx by 15-25% and OpEx by 25% relative to incumbent technologies. Telescope's lab-scale pilot aims to provide the key engineering studies and continuous operation demonstrations requested by several potential licensing customers.

"We're deeply grateful for CICE's support as we advance ReCRFT towards commercial deployment," said Jason Hein, Telescope CTO. "This lab pilot is the natural evolution of our research efforts with Standard Lithium, Natural Resources Canada, and Canada's Mining Innovation Commercialization Accelerator, and we're thrilled to enter this stage of technology translation."

"Telescope is revolutionizing the lithium purification process, streamlining the production of high purity lithium carbonate from low grade brine concentrates," said Sarah Goodman, CEO of CICE. "At a time when global demand for lithium for batteries is set to soar, we're proud to support their ambitious goals in advancing a low-cost, high-impact solution to meet and surpass market needs on our journey to net zero."

About Telescope

Telescope is a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. The Company builds and deploys new enabling technologies including flexible robotic platforms and artificial intelligence software that improves experimental throughput, efficiency, and data quality. Our aim is to bring modern chemical technology solutions to meet the most serious challenges in health and sustainability.

On behalf of the Board,

Telescope Innovations Corp.

Jeffrey Sherman, Chief Operating Officer
E: jeff@telescopeinn.com

About the B.C. Centre for Innovation and Clean Energy

The B.C. Centre for Innovation and Clean Energy (CICE) is an independent, not-for-profit corporation that provides early-stage funding (or non-dilutive investment) to fast-track the commercialization of British Columbia's most impactful clean energy solutions – from Canada to the world. We match the urgency and efficiency of the companies we fund, driving innovation like the planet depends on it. Because it does. Together with our climate-first community of innovators, industry leaders, academia, government, and Indigenous partners, we advance future pathways to net-zero – leveraging BC's clean energy advantages to attract investment, create good jobs and build sustainable economic prosperity for decades to come. www.cice.ca

Forward-Looking Information

Forward-looking information is based on a number of opinions, assumptions and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information.

Examples of such assumptions, risks and uncertainties include, without limitation, assumptions, risks and uncertainties associated with the global COVID-19 pandemic; general economic conditions; adverse industry events; the Company's ability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favorable terms; the ability of the Company to implement its business strategies; competition; and other assumptions, risks and uncertainties.

Forward-looking statements in this document include expectations surrounding Telescope's receipt of $400,273 from CICE, the capacity of ReCRFT to reduce lithium refinery plant CapEx by 15-25% and OpEx by 25% relative to incumbent technologies, the execution and outcome of key engineering studies and continuous operation demonstrations, the advancement of ReCRFT towards commercial deployment, and all other statements that are not statements of historical fact.

The forward-looking statements contained in this news release are made as of the date of this news release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/217327

FAQ

What is the funding amount Telescope Innovations (TELIF) received from CICE?

Telescope Innovations (TELIF) received $400,273 in early-stage funding from the B.C. Centre for Innovation and Clean Energy (CICE).

What is the purpose of the CICE funding for Telescope Innovations (TELIF)?

The funding will support Telescope Innovations (TELIF) in piloting its proprietary Recrystallization Refinement Technology (ReCRFT™) for producing battery-grade lithium carbonate from saltwater brines.

How much can Telescope Innovations' (TELIF) ReCRFT technology reduce lithium refinery costs?

Telescope Innovations' (TELIF) ReCRFT technology is estimated to reduce lithium refinery plant CapEx by 15-25% and OpEx by 25% compared to incumbent technologies.

What are the key advantages of Telescope Innovations' (TELIF) ReCRFT technology?

The key advantages of Telescope Innovations' (TELIF) ReCRFT technology include continuous operation, high process yield, high impurity tolerance, and reduced reagent utilization.

TELESCOPE INNOVATIONS CP

OTC:TELIF

TELIF Rankings

TELIF Latest News

TELIF Stock Data

19.90M
40.70M
22.38%
Biotechnology
Healthcare
Link
United States of America
Vancouver